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Abstract.  In S. cerevisiae lacking SHR3, amino acid 
permeases specifically accumulate in membranes of the 
endoplasmic reticulum (ER) and fail to be transported 
to the plasma membrane. We examined the require- 
ments of transport of the permeases from the ER to the 
Golgi in vitro. Addition of soluble COPII components 
(Sec23/24p,  Secl3/31p, and Sarlp) to yeast membrane 
preparations generated vesicles containing the general 
amino acid permease, Gaplp, and the histidine per- 
mease, Hiplp. Shr3p was required for the packaging of 
Gaplp and Hiplp but was not itself incorporated into 
transport vesicles. In contrast, the packaging of the 
plasma membrane ATPase, Pmalp, and the soluble 
yeast pheromone precursor, glycosylated  pro a factor, 
was independent of Shr3p. In addition, we show that in- 
tegral membrane and soluble cargo colocalize in trans- 
port vesicles, indicating that different types of cargo are 
not segregated at an early step in secretion. Our data 
suggest that specific ancillary proteins in the ER mem- 
brane recruit subsets of integral membrane protein 
cargo into COPII transport vesicles. 
I 
N S. cerevisiae and other eukaryotes, secreted proteins 
move  intracellularly  between  membrane-bounded 
compartments  via  transport  vesicles  (Palade,  1975; 
Pryer et al., 1992). Soluble  and integral membrane pro- 
teins destined for subcellular  compartments, the plasma 
membrane, or secretion are imported into the ER where 
folding, initial glycosyl modifications, and oligomer assem- 
bly takes place. Cargo molecules destined for transport are 
then targeted to the Golgi for further modification and 
sorting (Rothman, 1994; Schekman, 1992). The transport 
of membrane proteins to the plasma membrane (PM) 1 is 
essential for, among other functions, the maintenance of 
intracellular pH  and the transport of nutrients, such  as 
amino acids into the cell. The yeast genome encodes 17 
amino acid permeases of which 11 have defined substrate 
specificities. These proteins exhibit 30-60%  amino acid se- 
quence homology and contain 12 putative transmembrane 
domains (Andre, 1995; Schmidt et al., 1994). Components 
of the Sec machinery are required for permease transloca- 
tion into the ER (Green et al., 1992), and for export to the 
PM (Courchesne and Magasanik, 1983). 
Shr3p, a nonessential integral ER membrane protein, is 
Please address all correspondence to R. Schekman, Department of Molec- 
ular and Cell Biology, Howard Hughes Medical Institute, Barker Hall, 
University of California, Berkeley, CA 94720. Tel.: (510)  642-5686.  Fax: 
(510) 643-8493. 
1.  Abbreviations used  in  this paper:  COPII, cytosolic coat components; 
gpaF, glycosylated pro a  factor; MSS, medium speed supernatant; PM, 
plasma membrane. 
also required for the localization of amino acid permeases 
to the plasma membrane of S. cerevisiae in vivo (Ljungdahl 
et al., 1992). Immunofluorescence  localization showed that 
amino acid permeases were retained in the ER membrane 
of shr3 null mutant (Ashr3) cells. Shr3p acts pleitropically 
on the entire family of amino acid permeases. As a result 
of diminished levels of amino acid permeases in the PM, 
Ashr3 cells are resistant to high concentrations of histidine 
in the  growth medium. The transport of soluble  cargo, 
such as carboxypeptidase Y, et factor, and invertase, and 
membrane proteins, such as the plasma membrane ATPase 
(Pmalp), appeared unaffected by Ashr3 in vivo. Thus, Shr3p 
appears to be a specific accessory protein required for the 
early stage of secretion for a select group of homologous 
proteins, the amino acid permease family. 
Vesicle-mediated  transport of glycosylated  c~ factor pre- 
cursor (gpetF) from the ER to the Golgi complex has been 
reconstituted in vitro (Baker et al., 1988). Three protein 
fractions  comprising  two  hetero-oligomeric  complexes 
(Sec23/24p and Sec13/31p) and the small ras-like GTPase 
Sarlp constitute the cytosolic components (COPII) required 
for vesicle formation (Salama et al., 1993). Sarlp-GTP and 
the other proteins form the COPII coat around the vesicle 
that disassembles upon hydrolysis of GTP by Sarlp, allow- 
ing fusion of an uncoated vesicle with Golgi membranes 
(Barlowe et al., 1994). Recently, these transport vesicles 
were also found to carry the GPI (glycosylphosphatidyl- 
inositol)  anchored cell wall protein Gaslp (Doering and 
Schekman, 1996). In addition to cargo proteins,  COPII 
captures the putative vSNARES, Sec22p, Betlp, and Boslp 
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large peripheral membrane protein Secl6p is involved in 
the formation of ER-derived vesicles in vivo and is incor- 
porated into the vesicles in vitro (Espenshade et al., 1995). 
Another  transport  pathway composed  of the  coatomer 
subunits  and  Arflp  (COPI)  promotes  vesicle  budding 
originating from ER membranes in vitro (Bednarek et al., 
1995). Cargo proteins in COPI vesicles have not yet been 
identified,  although like  COPII  vesicles,  COPI  vesicles 
carry the same set of vSNAREs. 
The  view that vesicles indiscriminately transport  pro- 
teins from the ER to the Golgi (bulk-flow) is no longer 
tenable.  Recycling of escaped  proteins  from  the  Golgi 
complex, though it is important for cell viability, is not the 
principle means by which protein sorting is achieved. The 
separation of proteins destined for transport from those 
designed to remain in the ER is achieved primarily at the 
moment of transport vesicle budding from the ER. Inte- 
gral ER membrane proteins such as Sec61p, the transloca- 
tion pore, and Secl2p, which is closely involved in the bud- 
ding event, as well as the abundant soluble ER chaperone, 
Kar2p (BiP), are excluded from transport vesicles (Rexach 
et al., 1994). Sorting may be achieved by adaptor proteins 
such as Emp24p, a transmembrane protein that may be 
involved in the concentration of a subset of secretory pro- 
teins  into  COPII  vesicles  (Schimmoller  et  al.,  1995). 
Aemp24 cells transport  a  factor, acid phosphatase,  and 
vacuolar proteins normally, but Gaslp and invertase trans- 
port are delayed. Gaslp exit from the ER is further regu- 
lated by GPI anchor attachment (Doering and Schekman, 
1996). Emp24p and the GPI anchor may be recognized by 
subunits of the COPII coat allowing the capture of bound 
cargo  molecules  while  excluding resident  proteins  that 
lack a transport signal (Schekman and Orci, 1996). 
We  sought  additional  examples  of  protein-selective 
packaging  functions  and  considered  the  possiblity  that 
Shr3p may serve to capture the amino acid permeases into 
transport vesicles. The requirement for Shr3p in the spe- 
cific packaging of the permeases and other integral mem- 
brane  and soluble cargo was tested in vitro using mem- 
brane preparations derived from SHR3 wild-type and null 
mutant strains.  Our studies show that Shr3p  specifically 
promotes the entry of the permeases into the same COPII 
vesicles that collect other secretory proteins such as a  fac- 
tor precursor. However, Shr3p appears not to be a cargo 
adaptor because Shr3p remains localized to the ER mem- 
brane. 
Materials and Methods 
Materials and Media 
Unless otherwise noted, reagents were purchased from Sigma Chemical 
Co. (St. Louis, MO). SUD and SPD are synthetic minimal media (6.7 g/1 
yeast nitrogen base without ammonium sulfate and amino acids, Difco 
Laboratories Inc., Detroit, MI), supplemented with 20 g/l glucose, and 1.0 g/l 
urea or proline (1.0 g/l), respectively (Ljungdahl et al, 1992).  Where re- 
quired, SPD was supplemented with either 1 mM or 30 mM L-histidine; 
appropriate volumes of a filter sterilized 0.5 M L-histidine stock solution 
were added and the pH was adjusted to 5.5 with 10 N NaOH. The concen- 
tration of yeast nitrogen base in SUD and SPD is fourfold higher than the 
amount normally used in other synthetic media. MVD is a standard syn- 
thetic minimal medium (6.7 g/1 yeast nitrogen base without amino acids, 
Difco) supplemented with 20 g/l glucose. YPD is a complex medium (10 g/1 
Bacto yeast extract, 20 g/l Bacto peptone, Difco) supplemented with 20 g/l 
glucose. Solid  media were  made by  the addition  of 15  g/l  Bacto  agar 
(Difco). aSS-labeled  prepro a  factor and crude RSY607 yeast cytosol (~25 
mg protein/ml) were prepared as described (Baker et al., 1988).  COPII 
components were purified as described (Salama et al., 1993; Barlowe et al., 
1994). 
Yeast Strain and Plasmid Constructions 
Yeast strains are listed in Table I, and the plasmids used are listed in Ta- 
ble II. All yeast strains are isogenic derivatives of AA280. A spontaneous 
Ade + revertant of AA280 was isolated and crossed to AA288, the result- 
ing diploid was sporulated and tetrads dissected. Two spore-derived colo- 
nies with the desired genotypes resulted in PLY120 and PLY127. The 
ADE2 gene was deleted in PLY127 by cotransformation with BamHI lin- 
earized pPL131 and the URA3 based vector YCp50. A  red Ade-  Ura + 
transformant was isolated, and the loss of the YCp50 vector was selected 
for by growth on 5-fluoro orotic acid (5-FOA) resulting in strain PLY132 
(Boeke et al., 1984).  PLY170 and PLY171 are derived from meiotic seg- 
regants of a diploid strain obtained by mating PLY120 with PLY132. The 
diploid strain PLDYll6,  obtained by mating PLY170 and PLY171, was 
transformed with a  linear EcoRI-SalI  fragment of DNA derived from 
pPL288  containing shr3A5::hisG-URA3-hisG  (Alani  et  al.,  1987).  One 
Ura +  transformant was sporulated and  tetrads  dissected.  PLY214  and 
PLY223 are meiotic segregants of this transformant. Resistance to 30 mM 
histidine  segregated  2:2  and  was  100%  linked  to  the  URA3  marker. 
PLY223 was propagated on medium containing 5-FOA to attain the un- 
marked deletion  of shr3A6  resulting in  PLY229.  PLDYll6  was trans- 
formed to Ade+ with a linear EcoRI-KpnI fragment of DNA containing 
hiplA2::ADE2  derived from plasmid pPL296. PLY198 is a  meiotic seg- 
regant  from  one  such  transformant.  PLY198  was  subsequently trans- 
formed with a linear EcoRI-SalI fragment of DNA derived from pPL288 
containing  shr3A5::hisG-URA3-hisG  to  create  PLY202.  PLY202  was 
propagated on media containing 5-FOA to attain the unmarked deletion 
oI shr3A6 resulting in PLY204. MKY951 and MKY952 were made by inte- 
grating pRS306(HA-PMA1) into the PMA1 locus of PLY214 and PLY229, 
respectively. The integration  of SalI  digested pRS306(HA-PMA1)  dis- 
rupted pmal  and created a  full-length version of PMAI  containing the 
HA epitope tag. Chromosomal integration was verified by PCR, and ex- 
pression of the full-length Pmalp-HA product was monitored by immuno- 
blotting spheroplast lysates from transformed yeast cells. 
Plasmids were constructed using standard molecular biological proce- 
dures. The unmarked ade2A2 was constructed by digesting pPL130 with 
BglII and religating to create pPL131. It should be noted that the ade2A2 
construct disrupted genes flanking the ADE2 locus: 5'  a  protein of un- 
known function, and 3' the RGA1 gene was truncated (Stevenson et al., 
1995). The ade2A2 allele did not noticeably affect the growth rate, mating, 
or sporulation of yeast strains. Importantly, the ade2d2  allele did not af- 
fect any of the shr3 mutant phenotypes, pPL288 was constructed by insert- 
ing a blunt end 5-kb BgllI-BamHI hisG-URA3-neo-hisG cassette isolated 
from  pSE1076  (Allen  and  Elledge,  1994)  into  HindlII-XhoI  digested 
pPL216,  made blunt by treatment with Klenow fragment, pPL261  was 
made by inserting the XbaI-SalI fragment containing SHR3::FLU2  iso- 
lated from pPL230 into XbaI-SalI digested YCp405 (Ma et al., 1987). 
Plasmids used to analyze Hiplp were constructed as follows, pPL248 
was created by inserting the 3-kb EcoRI-SalI fragment containing HIP1 
from pJT19 into EcoRI-SalI digested pRS316 lacking the BamHI site in 
the polylinker;  pPL273  was constructed by  inserting the larger  5.5-kb 
XhoI HIP1 containing fragment from pJT19 into XhoI digested pRS316 
(Sikorski and Hieter, 1989). pPL253 was constructed by digesting pPL248 
with BamHl and BgllI after which the 2.2-kb BglII fragment containing 
ADE2 from pASZll was inserted (Stotz and Linder, 1990).  pPL282 was 
made  by  digesting  pPL273  with  EcoRI-SalI  and  inserting  the  4-kb 
EcoRI-SalI fragment containing hiplA::ADE2 from pPL253. The insert 
of pPL282 was cloned into KpnI-EcoRI digested pBSII SK (+)  (Strat- 
agene, La Jolla, CA) resulting in the final deletion construct pPL296. 
The construction of pPL321 containing a  fully functional Hiplp-myc 
required  multiple  steps,  pPL302  was  made  by  digesting pPL273  with 
EcoRI-NotI, the ends were made blunt and religated, pPL304 was con- 
structed by digesting pPL302 with XbaI to remove a  1.5-kb XbaI frag- 
ment, following which the ends were filled in and religated. Epitope tag- 
ging of HIP1 was performed as described by Kolodziej and Young (1991) 
using pPL304 as the starting vector and site directed insertion mutagenesis 
(Kunkel et al., 1987).  pPL308 contains an XbaI site introduced into the 
HIP1 sequence between amino acid residues 23 and 24. An oligomer en- 
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pared with helper phage M13K07 (Vieira and Messing, 1987)  in the dut- 
ung- E. coli host, RZ1032 (Kunkel et al., 1987). After elongation, ligation, 
and transformation into a dut  + ung  + host, plasmid DNAs were screened 
for the presence of the new XbaI site. An XbaI flanked cloning cassette, 
encoding the c-myc epitope reiterated three times, was inserted into the 
unique XbaI site of pPL308 resulting in pPL315. To reconstruct sequences 
3' of HIP1, we digested pPL315 with AvrlI and the 3 kb AvrlI fragment of 
pPL302 was inserted. This last cloning step resulted in pPL321 and rein- 
troduced the previously deleted 1.5-kb XbaI fragment. 
pRS306  (HA-PMA1)  was made by introducing the 2.4-kb  HindlII- 
BamHI  fragment of pRS305(HA-PMA1)  (Ziman et  al.,  1996)  into the 
multiple cloning site of pRS306 (Sikorski and Hieter,  1989)  lacking the 
Sail endonuclease site. The Sail site had been removed previously by Sail 
digestion of pRS306 followed by treatment with the Klenow enzyme and 
ligase. The resulting plasmid contained a 1.6-kb fragment of PMA1 encod- 
ing the epitope tagged NH  2 terminus of Pmalp. 
Plasmids encoding epitope-tagged proteins were transformed into yeast 
using the lithium acetate procedure (Guthrie and Fink, 1991).  Transfor- 
mants were chosen that expressed the plasmid-encoded proteins as de- 
tected by SDS-PAGE immunoblotting of whole cell lysates. The c-myc 
epitope is recognized by the monoclonal antibody 9El0 (Evan et al., 1985) 
and the HA epitope is recognized by the monoclonal antibody 12CA5 
(Wilson et al., 1984).  The growth phenotype of transformant and parent 
strains were similar on 1 mM and 30 mM histidine containing SPD media, 
confirming that the SHR3 locus had not been affected. 
Microsome Preparation 
Yeast  cultures  of  PLY204[pPL321]  [pPL261],  PLY198[pPL321],  and 
PLY204[pPL321]  grown at  30°C on  appropriately  supplemented MVD 
solid media were used to inoculate stock cultures of supplemented SUD 
broth. Stock SUD cultures grown at 24°C to 70D~o/ml were used to inoc- 
ulate YPD broth cultures grown at 24°C overnight to 10D60o/ml. Cells (3 1 
total, 10D~0/ml) were harvested, and microsomal membranes prepared 
as  described  (Wuestehube and  Schekman,  1992).  Purified  microsomal 
membranes were adjusted to 40 OD280 (~8 mg protein/ml) in B88. The 
preparation was divided into 50-~1 aliquots, frozen in liquid nitrogen, and 
stored at -80°C. 
Microsome-based Cargo Packaging Assay 
Two budding reactions were prepared  simultaneously, one for ct factor 
precursor analysis and  the other for  immunoblotting. Microsomes (0.4 
rag) were thawed on ice, 35S-labeled  prepro-c~  factor was added to one of 
the reactions, and both preparations incubated with 1 ×  ATP regenera- 
tion mix (Baker et al.,  1988)  in a  volume of 160  ill for 25 rain at 10°C. 
Membranes were incubated on ice for 5 min, washed three times with 1 ml 
B88 (12,000 g), and resuspended in B88. Budding reactions (50 pA) were 
prepared in duplicate containing N50 p.g microsomes, 0.1 mM GTP, 1 × 
ATP  regeneration  mix, and  either  purified  COPII  components  (1  ~g 
Secl3/31p,  1  I~g Sec23/24p, and 0.5  p.g Sarlp)  or 50 p~g cytosol supple- 
mented with 0.3 Ixg Sarlp. After incubation for 60 min at 20°C, a portion 
of the total reaction (Total)  and the medium-speed supernatant (MSS) 
(12,000 g, 5 min.) were collected. The percent of 35S-labeled  prepro-a fac- 
tor packaged into vesicles was determined by dividing the amount of pro- 
tease-protected, Con A-precipitable 35S-gpctF in the MSS by the amount 
in the Total fraction as described (Rexach and Schekman, 1991). For anal- 
ysis of vesicle proteins, the MSS was transfered to siliconized Eppendorf 
tubes (USP, San Leandro, CA) and sedimented in the TLA100.3 for 15 
rain at 90,000 g, at 4°C. Total and high speed pellet fractions were heated 
in 1X SDS-PAGE sample buffer for 10 min at 55°C and proteins were sep- 
arated using 12.5% SDS-PAGE and immunoblotted. For the comparison 
of  budding  from  microsomes  prepared  from  PLY198[pPL321]  and 
PLY204[pPL321],  250  p~l reactions contained  100  p~g membranes incu- 
bated with 5 Ixg Secl3/31p, 5 ttg Sec23/24p, and 2.5 I~g Sarlp, or 250 Ixg cy- 
tosol supplemented with 1.5/zg Sarlp. 
Semi-Intact Yeast Spheroplasts 
Yeast  cultures  of  PLY129[pPL269],  PLY134[pPL269],  MKY951,  and 
MKY952  grown  on  appropriately  supplemented MVD  solid  media at 
30°C were used to inoculate stock cultures of supplemented SUD broth. 
Stock cultures grown to an ODr00/ml of 2-6 at 24°C were used to inoculate 
overnight YPD broth cultures that were grown to an ODr0o/ml of 1-2 at 
24°C. Cells were harvested, washed twice in MVD, resuspended in supple- 
mented MVD to 5 OD600/ml, and shaken at 30°C for 15 min. The cultures 
were labeled with 1 mCi/60 OD600/ml 35S-Promix (1,200 Ci/mmol, Amer- 
sham) for 3 min at 30°C. Metabolic activity was stopped by the addition of 
NaN  3 (20  mM final). The cells were  incubated  on ice  for  15  min and 
washed with cold 20 mM NaN  3. Spheroplast preparation and lysis were 
performed as described (Doering and Schekman, 1996). 
Immunoprecipitation of cell wall protein (CWP) with polyclonal anti- 
CWP, prepared by T. Doering and J. Campbell (Univ. of California, Berke- 
ley, CA) as described (Sanz et al., 1987),  and Gaplp-HA from 3SS-labeled 
semi-intact spheroplast preparations of the isogenic pair PLY129[pPL269] 
and PLY134[pPL269] showed less overall protein labeling in Ashr3 cells, 
however the ratio of the two proteins was the same in both strains. 
Semi-Intact Spheroplast-based Cargo Packaging Assay 
Gently lysed spheroplasts (20--30 OD600 U/tube, ~8 ~g protein/OD600U) 
were incubated in Stage I translocation reactions as described (Rexach et al., 
1994). Unlabeled washed membranes were exposed to 35S prepro a  factor 
and 1 ×  ATP regeneration mix at 10°C for 25 min, whereas 3ss metabol- 
ically labeled membranes were treated in a mock translocation reaction with 
only 1 ×  ATP regeneration mix. For urea treatment, before the budding 
reactions the membranes were resuspended in 2.5 M urea in B88 (100 ~1), 
incubated for 10 min on ice, and washed twice with 1 ml B88. Membranes 
were resuspended in a final volume of 80 ~1 B88. 
Budding reactions contained 10 p.1 of membranes (from 1.5-2.5 ODr00 
U cells), COPII components (1-2 Ixg Secl3/31p, 1-2 l~g Sec23/24p, and 
1 Ixg Sarlp) or 100 p.g crude cytosol supplemented with 1 ~xg Sarlp in a 50- 
p~l vol with 1 ×  ATP mix and 0.1 mM GTP. Reactions were incubated at 
25°C for 30 min. One-tenth of the sample was removed for analysis (To- 
tal), the remaining reaction mixture was centrifuged (12,000 g) at 4°C for 2 
min, and 25 i~1 of the supernatant (MSS) was collected. Total and MSS 
fractions from radiolabeled membranes were analyzed by immunoprecipi- 
tation.  Fractions from membranes containing translocated 358-a  factor 
precursor were analyzed for protease-protected gpaF as described (Rex- 
ach and Schekman, 1991). 
Vesicle Immunoisolation 
Vesicle budding reactions using semi-intact spheroplasts performed at 4°C 
and 25°C were scaled up tenfold and 350 }xl of the resulting MSS was col- 
lected and subjected to  flotation on a  35%-30%-25%-15%  Nycodenz 
gradient as described previously (Barlowe et al., 1994).  The upper three 
400-1~1 fractions were collected. For radiolabeled membranes, 5 I~l of the 
total reaction, 25 }xl of the MSS, and 50 }xl of each 400 p.l Nycodenz frac- 
tion were analyzed by immunoprecipitation. For unlabeled membranes, 
5 ~1 of the total reaction and 335 ~1 of each Nycodenz fraction were pre- 
cipitated in 20% TCA on ice for 5 min, and the precipitated material was 
collected by centrifugation (12,000 g, 20 min), washed with acetone, and 
sedimented again (12,000 g, 10 min). TCA precipitated material was ana- 
lyzed by SDS-PAGE immunoblotting. For membranes containing translo- 
cated 35S-prepro-a-factor, 10 I.Ll of the total reaction, 30 ~1 of MSS, and 
30 ~L1 of each Nycodenz fraction were analyzed for Con A-precipitable, 
protease-protected gpctF. To examine the possibility of nonspecific vesicle 
aggregation, we mixed 200 p.l of MSS containing Gaplp-HA vesicles and 
200 i~1 of MSS containing 35S prepro-a-factor vesicles on ice before Nyco- 
denz flotation and immunoisolation. 
To immunoisolate vesicles, we discarded the top 100 ~1 of the gradient, 
and the following 375 Izl was collected and 20 ILl incubated in 5% BSA/ 
PBS  (137  mM NaC1,  2.7  mM KC1,  4.3  mM Na2HPO4.7H20 ,  1.4  mM 
KH2PO4) overnight at 4°C in siliconized Eppendorf tubes (USP, San Le- 
andro, CA) with 10 ILl (0.5 mg/ml) anti-HA epitope monoclonal antibody 
(12CA5,  Boehringer  Mannheim,  Indianapolis,  IN)  or  affinity-purified 
anti-Sec22 polyclonal antibody (1 mg/ml) (Bednarek et al., 1995),  in the 
presence and absence of 1 mg/ml HA peptide (Boehringer Mannheim) or 
0A  mg/ml Sec22p-GST fusion protein  (Bednarek  et  al.,  1995),  respec- 
tively. Immunoprecipitated material was washed 4 × with 0.1% BSA/PBS, 
transferred to a new tube, and washed once with 50 mM NaC1/10 mM Tris- 
C1, pH 7.5 For nonradiolabeled samples, immunoisolated vesicles were 
subjected to SDS-PAGE immunoblotting and 125I-Protein  A. Immunore- 
active proteins were  detected  using a  Phosphorimager (Molecular Dy- 
namics, Sunnyvale, CA). Radiolabeled Gaplp-HA in a portion of the to- 
tal membrane material, the MSS, and the immunoisolated material were 
immunoprecipitated under denaturing conditions with the HA antibody. 
lmmunoprecipitates were washed, subjected to SDS-PAGE, and analyzed 
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Source or 
Strain  Genotype  reference 
AA280  MATc~ ura3-52 his3A200 lys2A201  ade2  Antebi and Fink,  1992 
AA288  MATa ura3-52 leu2-3, 112 lys2A201  ade2  Antebi and Fink,  1992 
PLY120  MATa ura3-52 leu2-3,  112 his3 A200 tys2 A201  This work 
PLY 127  MATa ura3-52 lys2A201  This work 
PLY129  MATa ura3-52 leu2-3, 112 lys2A201  ade2 gapl A::LEU2  Ljungdahl et al., 1992 
PLY 132  MA Tc~ ura3-52 lys2 A  201 ade2 A2  This work 
PLYI34  MATa ura3-52 leu2-3, 112 lys2A201  ade2 gapl A::LEU2  Ljungdahl et al., 1992 
shr3Al:: URA3 
MATa ura3-52 leu2-3, 112 lys2A201  ade2A2 
MATce ura3-52 his3A200 lys2A201  ade2 A2 
MATa ura3-52 lys2A201  ade2A2 hipl A2::ADE2 
MATa ura3-52 lys2A201  ade2A2 hipl A2::ADE2 
shr3A5::hisG-URA3-hisG 
MATa ura3-52 lys2A201  ade2 A2 hipl A2::ADE2 shr3A6 
MATer ura3-52 lys2A201  ade2A2 
MATa ura3-52 lys2A201  ade2A2 shr3A5::hisG-URA3-hisG 
MATa ura3-52 lys2A201  ade2 /t2 shr3A6 
MATa ura3-52 lys2 A201 ade2A2 pmaI::HA-PMAI:URA3 
MATc~ ura3-52 lys2A201  ade2A2 pmal::HA-PMAI:URA3 
shr3A6 
PLY170  This work 
PLY 171  This work 
PLY 198  This work 
PLY202  This work 
PLY204  This work 
PLY214  This work 
PLY223  This work 
PLY229  This work 
MKY951  This work 
MKY952  This work 
Table 1I. Plasmids 
Source or 
Name  Description  reference 
pJTl9  9-kb fragment containing HIPI in YEp24  Tanaka and Fink, 1985 
pPL130  6.2-kb BamHI fragment containing ADE2 in  Ljungdahl et al., 1992 
pUCI9 
pPL131  ade2 A2 in pUC 19  This work 
pPL216  shr3A3 in pBSII SK(+)  Ljungdahl et al., 1992 
pPL230  SHR3::FLU2  in pRS316  Ljungdahl et al., 1992 
pPL248  3-kb EcoRI-SalI  fragment containing HIP1 in  This work 
pRS316(ABamHI) 
pPL253  4-kb EcoRI-Sall fragment containing  This work 
hiplA2::ADE2 in pRS316(ABamHI) 
pPL261  SHR3::FLU2 in YCp405  This work 
pPL269  GAPI::FLU1 in YCp405  Ljungdahl et al., 1992 
pPL273  5.5-kb XhoI fragment containing H1P1 in  This work 
pRS316 
pPL282  6-kb KpnI-EcoRl fragment containing  This work 
hiplA2::ADE2 in pRS316 
pPL288  5.7-kb EcoRI-Sall fragment containing  This work 
shr3A5::hisG-URA3-hisG in pBSII SK(+) 
pPL296  6-kb Kpnl-EcoRI fragment containing  This work 
hiplA2::ADE2 in pBSII SK(+) 
pPL302  5.5-kb XhoI fragment containing HIP1 in  This work 
pRS316(AEcoRI-NotI) 
pPL304  4-kb XhoI fragment containing HIP1 in  This work 
pRS 316(AEcoRI-NotI) 
pPL308  4-kb XhoI fragment containing HIP1-XI in  This work 
pRS316(AEcoRI-NotI) 
pPL315  4.1-kb XhoI fragment  This work and Kornitz, D., 
containing HIPl::myc3X1 in  unpublished data 
pRS316(AEcoRI-NotI) 
pPL321  5.6-kb XhoI fragment containing  This work 
HIPl::myc3X1 in pRS316(AEcoRI-NotI) 
pRS305-(HA-PMA1)  HindllI-BamHl fragment containing HA-  Ziman et al., 1996 
PMA1 in pRS305(ASalI) 
pRS306-(HA-PMA1)  HindlII-BamHI fragment containing HA-  This work 
PMA1 in pRS306(ASalI) 
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treated immunoisolated material with protease, followed by solubilization 
and Con A precipitation of the protease-protected material. This quantity 
was compared with the amount of protease-protected, Con A-precipita- 
ble 35S-gpctF  in the native immunoprecipitation supernatant. 
Immunoprecipitation  and Western Blotting 
Immunoprecipitation reactions were prepared by heating the sample in 
B88 with an equal volume of denaturing buffer (1% SDS, 50 mM Tris, pH 
7.4, 1 mM EDTA, and 1 mM PMSF) for 10 min at 50°C. The sample was 
adjusted to 1 ml with IP buffer (150 mM NaC1, 1% Triton X-100, 0.05% 
SDS, 15 mM riffs CI, pH 7.5),  10 ixl (5 I~g) HA antibody, and 50 ~1 30% 
protein G-Sepharose in PBS, and the reactions were incubated for 2 h, ro- 
tating at 25°C. Immunoprecipitates were washed as described (Baker et al., 
1988).  Immunoprecipitated material was heated in reducing, denaturing 
sample buffer at 55°C for 10 rain, resolved by SDS-PAGE, and analyzed 
using a Phosphorimager. 
For immunoblotting, proteins were heated in sample buffer at 55°C for 
10 min, resolved by SDS-PAGE, and transferred to 0.2 ~m nitrocellulose 
(Millipore, Bedford, MA) or PVDF (Millipore) at 250 mA for 1.5 h. Strips 
of the blot were incubated at 25°C for 1 h  with 3%  nonfat dry milk in 
TBST (50 mM Tris-HC1,  pH 7.4, 150 mM NaC1, 0.1% Tween 20), and in- 
cubated for 2 h with affinity-purified anti-Sec61p polyclonal antibodies (1: 
5,000  in TBST)  (Stifling et al., 1992),  affinity-purified anti-Sec22p poly- 
clonal  antibodies  (1:1,000),  anti-myc  epitope  monoclonal  antibodies 
(9El0, 1:3,000)  (Evan et al., 1985), anti-HA antibodies (1:3,000),  or puri- 
fied lgG (~1 mg/ml) from anti-Betlp polyclonal antibodies (1:500)  (Rex- 
ach et al., 1994).  Immunoreactive proteins were detected by chemilumi- 
nescence (ECL, Amersham) and autoradiography, or by 125I-Protein A 
(ICN, Biomedicals, Inc., Costa Mesa, CA) and Phosphorimaging. 
Results 
Amino Acid Permeases Hipl and Gapl, but Not the 
Permease Chaperone Shr3p, Are Packaged into COPII 
Transport Vesicles 
The yeast pheromone precursor, glycosylated pro-~ factor 
(gpaF), is a marker for soluble protein cargo in secretory 
vesicles that bud from ER membranes in vitro (Baker et al., 
1988; Rexach and Schekman, 1991). In this budding assay, 
radiolabeled prepro-tx factor is posttranslationally translo- 
cated  into  ER  membranes  where  its  signal  sequence  is 
cleaved  and  it  becomes  core  glycosylated.  When  such 
membranes  are  incubated  with  purified  COPII  compo- 
nents or cytosol, gpetF is packaged into vesicles that can be 
separated  from  larger  membranes  by  a  medium-speed 
centrifugation step.  The efficiency of gpaF packaging is 
measured  as  the  fraction of total  gpaF  found  enclosed 
within vesicles in the medium-speed supernatant fraction 
(MSS). 
To investigate the packaging of amino acid permeases in 
vitro,  we  introduced  single  copy  plasmids  encoding  an 
epitope-tagged permease  into  yeast  strains  containing  a 
disruption of the wild-type permease gene (Tables I  and 
II).  Plasmids  pPL269  and  pPL321  encoding  the  tagged 
permeases Gaplp-HA and Hiplp-myc were transformed 
into the respective permease deletion strains PLY129 and 
PLY198. Epitope-tagged Gaplp-HA and Hiplp-myc are 
expressed and are localized to the PM where they are fully 
functional (Ljungdahl et al.,  1992;  and data not shown). 
Strain PLY204 which has deletions in the HIP1 and SHR3 
loci was  transformed with  pPL261  encoding HA-tagged 
Shr3p  (Shr3p-HA),  and  pPL321,  encoding  Hiplp-myc. 
Strains  deleted  in  SHR3  and  transformed  with  the 
epitope-tagged  version  of  SHR3  behaved  as  wild-type 
strains  with regard to growth on a  low concentration of 
histidine  and sensitivity to a  high concentration of histi- 
dine (Ljungdahl et al., 1992; and data not shown). 
The strains containing epitope-tagged proteins were an- 
alyzed using a modified budding assay (see Materials and 
Methods)  to  investigate  the  incorporation  of  integral 
membrane  proteins  into  transport  vesicles  in  vitro.  Mi- 
crosomal membranes prepared from Ashr3 cells express- 
ing Shr3p-HA and Hiplp-myc were incubated with either 
COPII proteins or whole cytosol to generate vesicles. The 
MSS  was  then  subjected  to  high-speed  centrifugation 
(90,000 g) to sediment the vesicles. Hiplp was detected in 
vesicle pellets from incubations containing nucleotide and 
either cytosol or the purified COPII components (Fig. 1). 
The  cargo  molecule  gpe~F and  the  putative  v-SNARE 
Sec22p were also found in these vesicles (Fig.  1). Similar 
results were obtained using purified yeast nuclei, a highly 
enriched preparation of ER membrane (data not shown). 
In  contrast,  Shr3p  and  the  ER  resident  protein  Sec61p 
were not detected in the vesicle fractions (Fig.  1).  These 
data  indicate  that  Hiplp  enters  COPII  vesicles whereas 
Shr3p is not transported out of the ER in vitro. 
We  wanted  to  examine  the  vesicle packaging  of per- 
meases  quantitatively, but contamination  of microsomal 
membranes with plasma membrane fragments prevented 
accurate  measurement  of the  low  level  of nascent  per- 
meases in transit from the ER. For this reason, we used 
spheroplast membranes prepared from cells that had been 
pulse-radiolabeled  for 3  min  with  [35S]methionine.  This 
short pulse essentially labels only ER transport intermedi- 
ates. Such pulses have previously been used to biochemi- 
cally  follow  the  ER  forms  of Pmalp,  another  integral 
membrane protein destined for the PM (Chang and Slay- 
Figure 1.  Packaging of Hiplp-myc from ER membranes in vitro. 
Microsomes made from PLY204[pPL261][pPL321] were used in 
duplicate vesicle budding reactions which contained: GTP,  nucle- 
otides  alone;  COPI1, nucleotides  and  purified  COPII compo- 
nents; Cyt, nucleotides and cytosoi supplemented  with Sarlp; H, 
COPII components without membranes; and C, Cytosol without 
membranes.  Medium  speed  supernatant  (MSS) fractions  col- 
lected by high speed centrifugation and one-third of the total re- 
action mixture (Tom/) were resolved by SDS-PAGE, and immu- 
nobiotted using anti-myc, anti-Sec61p, anti-Sec22p, and anti-HA 
antibodies, followed by ECL detection and autoradiography.  In 
parallel duplicate reactions where 35S-prepro-et-factor  was trans- 
located  posttranslationally  into the  microsomes,  protease-pro- 
tected 35S-gpaF in the MSS was measured and the average of the 
values are indicated at the bottom of the figure. 
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the COPII components. PLY129[pPL269] permeabilized sphero- 
plasts  were  used  in  duplicate  vesicle  budding  reactions.  The 
membranes were washed in 2.5 M urea for 10 min on ice and then 
washed once with B88 to decrease the amount of COPII compo- 
nents that remained on the membrane. Reactions contained:  no 
nuc, COPII components;  COPII, nucleotides  and COPII compo- 
nents; Cyt, nucleotides and cytosol supplemented with Sarlp; and 
nucleotides  and COPII reagents without  Secl3/31p  (13-), Sec23/ 
24p (23-), or Sarlp (Sarl-), respectively. (A) One-fifth of the to- 
tal reaction mixture (Total) and the complete MSS fractions were 
immunoprecipitated with anti-HA mAb. The immunoprecipitate 
was resolved by SDS-PAGE and analyzed  with a phosphorim- 
ager. (B) Quantitation of phosphorimager signals corresponding 
to radiolabeled Gaplp-HA expressed as an average of the per- 
cent of Gaplp-HA in the MSS of each reaction compared with 
the  total  reaction.  (C)  In  duplicate  parallel  reactions  using 
PLY129[pPL269]  permeabilized  spheroplasts,  the  amount  of 
trypsin resistant  35S-gpctF present in the MSS compared with the 
total reaction mixture was  measured and the  average value  is 
shown for each of the assay conditions described  above. 
man,  1991).  Because we were unable  to immunoprecipi- 
tate Hiplp from radiolabeled membranes, the Gaplp per- 
mease was examined in this modified assay. 
Perforated  spheroplasts  were  prepared  from  radiola- 
beled gaplA cells expressing Gaplp-HA and used in bud- 
ding reactions. Gaplp-HA was immunoprecipitated from 
the MSS in reactions that contained GTP, ATP, and either 
whole cytosol or all three purified COPII proteins (Fig. 
2 A); omission of any one COPII protein reduced the level 
of Gaplp-HA packaging. Immunoprecipitated Gaplp-HA 
was packaged with 35-45% efficiency into COPII vesicles 
(Fig. 2 B), similar to that for et factor precursor (Fig. 2 C). 
The dependence  on each  of the  COPII components for 
packaging was also found for Hiplp using the microsome 
assay  described  above  (data  not  shown).  These  results 
demonstrate  that  the  membrane permeases, like  soluble 
cargo, require each of the COPII components and nucle- 
otide for packaging into transport vesicles. 
Shr3p Is Required for In Vitro Packaging of Permeases 
into Vesicles 
We next examined the effect of an shr3 null mutation on 
the ability of the permeases to exit the ER in vitro. Hiplp 
packaging from SHR3 and dshr3 membranes was investi- 
gated  using  microsomal membranes and  an immunoblot 
assay. Hiplp-myc was not detected above background lev- 
els in the MSS in reactions using ~shr3 membranes with 
COPII or cytosol (Fig. 3 A). A  quantitative difference in 
permease  packaging  from SHR3  and  Ashr3  membranes 
was  determined  using  3-min  pulse-labeled  membranes 
prepared from isogenic cells expressing Gaplp-HA. z~shr3 
membranes  did  not  release  immunoprecipitable  Gaplp 
into  the  MSS  in  reactions  containing  either  cytosol  or 
COPII (Fig. 3 B). By quantitative phosphorimager analy- 
sis,  we  found  that  Gaplp  packaging  into  vesicles  from 
dshr3 membranes was reduced at least 90% compared to 
SHR3 membranes (Fig. 3 C). These data demonstrate that 
the amino acid permeases require the ER resident mem- 
brane protein, Shr3p, to be packaged into transport vesi- 
cles in vitro. 
a Factor and Praalp Packaging into Vesicles Is 
Independent of Shr3p 
We investigated whether the effect of the Shr3p deletion 
was specific to the amino acid permeases, et factor secre- 
tion and transport of the major plasma membrane proton- 
translocating ATPase (Pmalp) are not affected in vivo by 
Ashr3 (Ljuugdahl et al., 1992).  We looked for the presence 
of these cargo in vesicles produced from 2,shr3 membranes 
in vitro. 35S-gpetF packaging was quantitfied from "mock- 
labeled"  permeabilized  spheroplasts  that  were  prepared 
similarly to the metabolically labeled membrane prepara- 
tions described  above. The  efficiency of gpaF precursor 
packaging was similar using SHR3 and ~shr3 membranes 
(Fig. 4 A). Although the experiment depicted in Fig. 4 A 
indicates  a  partial  reduction  in  gpetF  packaging  using 
COPII components with  z~shr3 membranes, this  pattern 
was  not  seen  in  assays  involving  other  isogenic  SHR3/ 
z~shr3 pairs (data not shown). Doubling the level of COPII 
proteins increased the efficiency of gpaF packaging from 
dshr3 membranes whereas no such stimulation of Gaplp 
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ing  into vesicles.  (A) Microsomes containing  Hiplp-myc were 
prepared from SHR3 and zlshr3 isogenic strains PLY198[pPL321] 
and PLY204[pPL321]. Duplicate vesicle budding  reactions con- 
tained: nucl, nucleotides;  COPll, nucleotides  and COPII compo- 
nents;  Cyt, nucleotides  and  cytosol  supplemented with  Sarlp. 
One-seventh of the total reaction mixture and the complete MSS 
of each reaction were analyzed by immunoblotting with anti-myc 
mAb and the signal  visualized  by ECL and autoradiography. 
(B)  3SS-pulse labeled  permeabilized  spheroplasts  containing 
Gaplp-HA were prepared from SHR3 and zlshr3 isogenic strains 
PLY129[pPL269]  and PLY134[pPL269].  Duplicate vesicle bud- 
ding reactions contained:  no nucl, COPII components;  COPII, 
nucleotides  and COPII components; Cyt, nucleotides  and cytosol 
supplemented with Sarlp; and 4°C, nucleotides  and cytosol sup- 
plemented with  Sarlp incubated at 4°C. Radiolabeted Gaplp- 
HA was immunoprecipitated from one-fifth of the total reaction 
mixture and the MSS from each reaction using anti-HA mAb. 
Immunoprecipitated material was resolved by SDS-PAGE and 
analyzed using a phosphorimager. (C) Quantitation of phosphor- 
imager signals correspond to the percent of GapIp-HA in the 
MSS  of each reaction compared with  the total reaction.  Solid 
(SHR3) and hatched bars (zlshr3) represent the average of three 
data sets. 
packaging from zlshr3  membranes was observed (data not 
shown). These results show that in vitro, as in vivo, vesicle 
transport of soluble cargo is independent of Ashr3. 
Next, we examined the packaging of Pmalp. The plasma 
membrane  ATPase  Pmalp  is  abundant,  comprising  at 
least 5-10% of the PM proteins (Serrano et al., 1986; Ser- 
rano, 1989), and consists of 8-10 transmembrane domains 
with its ATPase  activity localized  to  a  large cytoplasmic 
domain positioned after the first four transmembrane do- 
mains. Pmalp export is mediated by the  Sec pathway in 
vivo  (Chang  and  Slayman,  1991;  Brada  and  Schekman, 
1988;  Holcomb et al., 1988; Walworth and Novick, 1987). 
Epitope-tagged Pmalp was introduced  into  the  chromo- 
some at the PMA1 locus by integrative recombination in 
both  SHR3  and  Ashr3  cells.  Permeabilized  spheroplasts 
were prepared from 35S pulse-labeled (3 min) cells of each 
strain and used in the in vitro vesicle budding assay to as- 
sess  Pmalp  packaging.  Pmalp-HA  was  immunoprecipi- 
tated from the MSS in reactions using whole cytosol and 
either SHR3 or zlshr3  membranes (Fig. 4 B, quantitation 
in  Fig.  4  C).  Interestingly, COPII consistently  was  only 
half as efficient as cytosol in the packaging of Pmalp into 
vesicles (data not shown). These results demonstrate that 
Pmalp is a  detectable vesicle cargo protein in vitro, and, 
like a  factor, is independent of Shr3p. 
Factor Precursor and Gaplp-HA Reside in the 
Same Vesicle 
To further characterize the population of membranes that 
contain  the  amino  acid  permeases,  we  fractionated  the 
MSS on a Nycodenz step gradient such that small vesicles 
float to the  top whereas  larger membrane fragments re- 
main at the bottom (Barlowe et al., 1994).  Gaplp was de- 
tected in the same upper step of the gradient as gpaF and 
Sec22p,  whereas the ER membrane marker, Sec61p,  did 
not float (Fig. 5, A  and B). These data suggest that Gaplp 
resides in vesicles that have the same general properties as 
those that contain gp~xF. 
Sorting  of cargo molecules is thought  to occur at late 
stages  in  the  secretory pathway  (Harsay and  Bretscher, 
1995; Rothman, 1994). We were interested in determining 
whether  integral  membrane  and  soluble  cargo  proteins 
were  sorted  into  distinct  COPII  vesicles.  Because  the 
epitope tag on Gaplp is predicted to reside on the cyto- 
solic side of the membrane, and thus be accessible to anti- 
bodies,  we  had  the  opportunity  to  immunoprecipitate 
Gaplp-HA-containing vesicles to evaluate coincident lo- 
calization of gptxF.  Vesicle populations were immunoiso- 
lated  after flotation on  a  Nycodenz step gradient.  Nyco- 
denz  removes most  of the  COPII  coat  (Barlowe  et  al., 
1994)  allowing better epitope recognition by the antibody. 
Native immunoprecipitation using a saturating amount of 
anti-HA antibody recovered 65 % of the Gaplp-HA found 
in the Nycodenz-floated material; recovery was completely 
inhibited by the HA peptide (1 mg/ml). Anti-HA antibody 
coprecipitated 71%  of the gpetF and detectable amounts 
of the vSNAREs, Betlp and Sec22p, present in the Nyco- 
denz-floated vesicles (Fig.  5  C).  Similar results were ob- 
tained using cytosol or purified COPII components to gen- 
erate the vesicles. In addition,  we prepared a  mixture of 
vesicles, half carrying Gaplp-HA and not containing 35S-gpaF, 
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which were floated on a Nycodenz gradient. The presence 
of Gapl-HA-carrying vesicles did not cause the coisolation 
of 35S-gpetF recovered with anti-HA antibody (8%, back- 
ground level: 3-7%). These data indicate that only vesicles 
carrying  the  epitope  tag  were  immunoprecipitated  and 
thus  nonspecific  agglutination  of vesicles  did  not  occur 
during the procedure.  Our results support the hypothesis 
that soluble and membrane cargo reside in the same ER- 
derived transport vesicle and suggest that protein sorting 
occurs at a later step in secretion. 
Discussion 
We were interested in determining the requirements for in 
vitro packaging of the integral membrane amino acid per- 
mease proteins into transport vesicles. By modifying meth- 
ods described previously for the packaging of a  factor pre- 
cursor in vitro, we were able to follow newly synthesized 
integral membrane proteins as cargo molecules in ER-derived 
transport vesicles. A  similar approach was used to identify 
Gaslp, a GPI-anchored protein, as vesicle cargo (Doering 
and  Schekman,  1996).  We found that  Hiplp and  Gaplp 
are packaged into vesicles driven by Sec proteins found in 
a cytosol fraction, and that the same degree of packaging 
of these  cargo  could  be  achieved  using  purified  COPII 
components, Sec13/31p, Sec23/24p, and Sarlp (Figs. 1-3). 
Pmalp, another integral plasma membrane protein, was 
observed as cargo in vesicles generated from ER by crude 
cytosol (Fig. 4, B and C). Whereas the permeases were ex- 
ported  as  effectively  by  the  COPII  components  as  by 
whole yeast cytosol, the amount of Pmalp packaged into 
vesicles by the purified COPII components was only about 
half the amount observed using cytosol (data not shown). 
Thus, additional soluble factors may be required for the in 
vitro packaging of Pmalp into vesicles. Accumulation  of 
plasma membrane ATPases in proliferated ER upon  ex- 
pression  of dominant  lethal pmal  mutants  or  plant  PM 
ATPases in yeast suggests that a  limiting ER chaperone- 
type protein may be responsible for the transport of Pmalp 
to the PM (Harris et al., 1994; Villalba et al., 1992; de Ker- 
chove d'Exaerde et al., 1995). AST1 encodes a membrane- 
associated cytosolic protein suppresses the growth defect 
of mutant prnal  cells by localizing mutant Pmalp to the 
PM  (Chang  and  Fink,  1995).  Immunofluorescence  data 
show that Astlp is present in punctate  cytoplasmic loca- 
tions and  at the cell perimeter, but is excluded from the 
nucleus and the vacuole. These data suggest a possible role 
for cytosolic Astlp in Pmalp vesicle transport. 
Figure 4.  t~ factor precursor and Pmalp packaging into vesicles is 
unaffected by zishr3. (A)  In duplicate  parallel  reactions  using 
PLY129[pPL269]  and  PLY134[pPL269]  semi-intact  sphero- 
plasts,  the amount of trypsin resistant  35S-gpaF present in the 
MSS compared with the total reaction mixture was determined 
for each  of the  assay  conditions  described  in  Fig.  3  B.  Solid 
(SHR3) and hatched bars (Ashr3) represent the average of three 
data sets. (B) 35S-pulse-labeled permeabilized spheroplasts  were 
prepared from SHR3  and Ashr3 isogenic  strains  MKY951 and 
MKY952. Duplicate vesicle budding reactions contained:  Cyt, nu- 
cleotides  and cytosol supplemented with Sarlp; and 4°C, nucle- 
otides  and cytosol  supplemented with  Sarlp incubated at 4°C. 
Radiolabeled  Pmalp-HA  was  immunoprecipitated  from  one- 
fifth of the Total reaction mixture and the MSS from each reac- 
tion using anti-HA mAb. Immunoprecipitated material was re- 
solved by SDS-PAGE and analyzed using a phosphorimager. (C) 
In duplicate  parallel  reactions using MKY951 and MKY952 per- 
meabilized spheroplasts,  the amount of trypsin resistant 35S-gpaF 
present in the MSS compared with the total reaction mixture was 
determined for each of the assay conditions described  in B. Solid 
(SHR3) and hatched bars (dshr3)  represent the average of three 
data sets. 
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ing Gaplp-HA. (A) MSS generated in vesicle budding  reactions 
performed at 4°C or 25°C were subjected  to Nycodenz density 
gradient flotation.  Radiolabeled Gaplp-HA was immunoprecipi- 
tated using anti-HA mAb: T, one-fifth of the total budding reac- 
tion mixture;  M, the MSS from the budding  reaction;  and 1, 2, 
and 3, 400-~1 fractions collected  starting from the top of the Ny- 
codenz gradient.  Immunoprecipitated material was resolved by 
SDS-PAGE and analyzed  using a phosphorimager. The amount 
of 35S-gpctF present in the Nycodenz fractions is expressed as a 
percent of the amount loaded onto the gradient in a typical paral- 
lel experiment (average of duplicates).  (B) T membranes and Ny- 
codenz floated fractions 1, 2, and 3 described  in A were analyzed 
by  SDS-PAGE  immunoblotting  using  anti-Sec61p  and  anti- 
Sec22p antibodies,  and visualized by ECL autoradiography. (C) 
Vesicles purified by Nycodenz gradient flotation were immuno- 
precipitated with anti-HA mAb in the presence (+) or absence 
(-) of 1 mg/ml HA peptide. The Nycodenz floated material (To- 
tal)  and  the  immunoprecipitated material  (anti-HA)  were  re- 
solved  by  SDS-PAGE,  immunoblotted using  anti-Sec22p  and 
anti-Betlp antibodies,  and the proteins detected using 125I-Pro- 
tein A and Phosphorimager analysis. The amount of radiolabeled 
Gaplp-HA in immunoisolated vesicles is expressed as a percent 
of the amount in the Nycodenz floated fraction.  35S-gpetF in im- 
munoisolated vesicles is expressed as a percent of the material 
present in each native immunoprecipitation reaction. 
Nycodenz flotation and immunoprecipitation of the ves- 
icles showed that Gapl resides in the same vesicles as et fac- 
tor  precursor  and  the  putative  v-SNAREs,  Betlp,  and 
Sec22p (Fig. 5). It is not yet clear whether Pmalp resides 
in the same vesicles as other membrane and soluble cargo. 
These results show that permeases are transported out of 
the ER in COPII vesicles and implies that the separation 
of cargo with  different  destinations  occurs  at  a  step  be- 
yond the ER in the secretory pathway. 
Shr3p is clearly required  for the exit of the permeases 
Hiplp and Gaplp from the ER in vitro (Fig. 3). The defect 
in permease packaging by dshr3 membranes is not over- 
come by a soluble cytosolic factor. Although immunofluo- 
rescence  data  demonstrated  that  the  integral membrane 
protein Shr3p exists primarily in the ER (Ljungdahl et al., 
1992),  we  considered  the  possibility  that  Shr3p  entered 
secretory vesicles and then was recycled back to the ER. 
Unlike the vSNARE Sec22p (Rexach et al., 1994;  Yeung 
et  al.,  1995),  or  the  sorting  accessory  protein,  Emp24p 
(Schimmoller et  al.,  1995),  which  cycle between  the  ER 
and the c/s-Golgi, Shr3p is not packaged into cargo vesi- 
cles in vitro (Fig. 1). This behavior suggests that Shr3p is a 
true ER resident protein, interacting only transiently with 
the permeases before they enter cargo vesicles. 
The packaging of et factor precursor or Pmalp is inde- 
pendent of Shr3p (Fig. 4), thus Shr3p does not appear to 
be  a  universal  link  between  the  ER  membrane and  the 
budding machinery. The result that ~Ishr3 membranes are 
not generally defective in the export of PM proteins dem- 
onstrates  that  dshr3  membranes retain  a  normal sorting 
and budding apparatus. 
Shr3p  plays a  specific,  critical role  in  the  secretion  of 
permeases from the ER in vivo and in vitro. The presence 
of ER chaperones to regulate the  secretion of a  specific 
subset of proteins appears to be a wide-spread phenome- 
non  in  yeast  and  mammalian  cells  and  the  chaperone's 
function  depends  on  the  particular  secreted  protein.  In 
yeast, the soluble ER chaperone BiP functions in translo- 
cation and folding of soluble proteins (Gething and Sam- 
brook, 1992).  Calnexin plays a  role in  quality control of 
glycosylation before proteins are  allowed to exit the ER 
(Hammond  and  Helenius,  1995).  Previous  studies  have 
identified several membrane protein chaperones required 
for proper intracellular localization of secretory proteins, 
stabilizing intermediates of a growing oligomeric complex, 
and preventing the activity of proteins during their transit 
through  the  secretory  pathway.  Anplp  is  an  ER  mem- 
brane protein involved in the correct localization of early 
Golgi  glycosylation  machinery  (Chapman  and  Munro, 
1994). Vmal2p, a 25-kD integral vacuolar membrane pro- 
tein, is required for vacuolar ATPase (vATPase) assembly 
and influences the stability of the 100-kD and 17- kD inte- 
gral membrane subunits of vATPase (Hirata et al., 1993). 
The authors speculate that Vmal2p may be present along 
earlier steps in the secretory route to prevent the ATPase 
from transporting H ÷ into the ER and vesicular compart- 
ments.  Vma21p,  another  integral  membrane  protein  re- 
sponsible  for vATPase assembly, is thought  to cycle be- 
tween the ER and the Golgi and also stabilizes the 100-kD 
integral membrane component of the vATPase (Hill and 
Stevens, 1994). In human kidney cells, the 39-kD receptor- 
associated protein  (RAP)  binds the  low density lipopro- 
Kuehn et al. Permease Packaging  into COPII Vesicles  593 tein receptor-related protein (LRP) in the ER to modulate 
the aggregation and ligand binding activity of LRP along 
the secretory pathway (Bu et al., 1995). In Drosophila, the 
interaction between the cyclophilin NinaA and the opsins 
Rhl  and Rh2 closely resembles the relationship between 
Shr3p  and the permeases  in yeast.  In the absence of Ni- 
naA, Rhl  and Rh2, but not Rh3 and Rh4, accumulate in 
the ER, however, unlike Shr3p, NinaA is also found in dis- 
tal compartments of the secretory pathway (Baker et al., 
1994; Colley et al., 1991). 
It is possible that  Shr3p  acts in a  typical  "chaperone" 
fashion by influencing the conformation, assembly, or ac- 
tivity of the associated permeases. It is unlikely that Shr3p 
influences translocation of the permeases, because the lo- 
calization of transmembrane domains appears unperturbed 
in reporter-fusion constructs made with the permeases in 
Ashr3 cells (Gilstring, F., and P.O. Ljungdahl, unpublished 
data). If permeases oligomerize, Shr3p could facilitate sub- 
unit assembly in the ER or prevent premature oligomer- 
ization. Alternatively, Shr3p may act at the level of quality 
control  by  detecting  a  particular  mature  conformation 
achieved by the permease when it is ready to leave the ER. 
A  strong possibility exists that  Shr3p  and  other trans- 
port  chaperones  communicate  with the  budding  compo- 
nents of the Sec machinery. Shr3p could act either by con- 
tacting the permeases and the COPII components directly 
or by indirectly mediating permease  entry into transport 
vesicles. A  genetic approach is currently underway to in- 
vestigate the interaction of Shr3p and the COPII budding 
components. Acting as an intermediary between the per- 
meases and COPII, Shr3p could direct the budding com- 
ponents  to  an  area  of the  membranes  rich in  permease 
cargo proteins, thereby participating in permease packag- 
ing  without  leaving  the  ER.  Alternatively,  Shr3p  could 
mediate  the  interaction  of  the  permeases  with  a  cargo 
adaptor protein such as Emp24p. Shr3p could also play an 
active role in regulating permease secretion in response to 
stressful growth conditions. A cytosolic signaling molecule 
could  modulate  the  interaction  between  Shr3p  and  the 
permeases, and thereby change the number of permeases 
that are directed into a budded vesicle. The analytical  in 
vitro methods described in this paper can be used to ex- 
plore many of these possibilities. 
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